Canadian researchers advise hospitals to stock up on critical pieces of personal protective equipment (PPE) such as masks and respirators in anticipation of a potential pandemic. In advance of the 2009 H1N1 influenza pandemic, they point to the variation in what was known about the impact that an influenza pandemic might have on stockpiles of facial protective equipment (FPE) as well as on employees' ability to cope with pandemic situations.
Murray, et al. (2010) sought to describe the impact of H1N1 on FPE use and hospital employee absenteeism and conducted their study in a tertiary-care hospital and several community hospitals in Vancouver, Canada. They studied all individuals with influenza-like illness admitted to the three facilities from June 28, 2009 through Dec. 19, 2009 and recorded prospectively data on FPE use. Their research was published in Infection Control and Hospital Epidemiology.
The researchers report that 865 patients with influenza-like illness were admitted to the facilities participating in the study, and of these patients, 149 (17.2 percent) had laboratory-confirmed H1N1 influenza infection. The average duration of hospital stay for these patients was 8.9 days, and the average duration of ICU stay was 9.2 days. Murray, et al. (2010) report that 134,281 masks and 173,145 N95 respirators were used during the 24-week epidemic, double the weekly use of both items, compared with the previous influenza season. A ratio of three masks to four respirators was observed, and use of disposable eyewear doubled. The researchers say that healthcare facility absenteeism mirrored the community epidemiologic curve, with a 260 percent increase in employee sick calls at the epidemic peak.
Reference: Murray M, Grant J, Bryce E, Chilton P and Forrester L. Facial Protective Equipment, Personnel, and Pandemics: Impact of the Pandemic (H1N1) 2009 Virus on Personnel and Use of Facial Protective Equipment. Infect Control Hosp Epidemiol. September 2010.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.